基本信息
浏览量:0
职业迁徙
个人简介
Research interests
Many neuroimmunological conditions have the potential to result in devastating disability, including blindness, paralysis, epilepsy, and cognitive impairment. However, it is increasingly recognised that expedited recognition and diagnosis, and the institution of early and appropriate immunotherapy can result in excellent outcomes. Dr Ramanathan is committed to translational research including basic science projects which help us better understand what triggers autoimmunity, underlying mechanisms of disease pathogenesis, putative targets for the actions of antibodies, and targets for novel therapeutic agents. She also leads clinical projects with an emphasis on detailed clinical phenotyping which permits early recognition and diagnosis of these conditions, evaluating therapeutic responses, identifying the most effective treatment algorithms, and determinating features that optimise patients' outcomes.
Dr Ramanathan completed her PhD on the clinical and immunological characterisation of myelin oligodendrocyte glycoprotein (MOG) antibody-associated demyelination. In 2016, she established and has since been the lead investigator of the Australasian and New Zealand MOG Study Group. This is a unique collaborative platform of over 150 adult and paediatric neurologists from over 45 centres throughout Australasia, with the goal of better understanding and treating antibody-associated demyelination. She heads this collaboration, and works closely with Professor Russell Dale (paediatric neurologist/ neuroimmunologist) and Associate Professor Fabienne Brilot (scientist) at the Kids Neuroscience Centre on these patients. This research team is now responsible for one of the largest international cohorts of close to 500 paediatric and adult patients with MOG antibody-associated demyelination, and have led a number of important publications for the field.
Dr Ramanathan has been the chief investigator for scholarships and grants providing research funding from the National Health and Medical Research Council (NHMRC) and the Brain Foundation.
Many neuroimmunological conditions have the potential to result in devastating disability, including blindness, paralysis, epilepsy, and cognitive impairment. However, it is increasingly recognised that expedited recognition and diagnosis, and the institution of early and appropriate immunotherapy can result in excellent outcomes. Dr Ramanathan is committed to translational research including basic science projects which help us better understand what triggers autoimmunity, underlying mechanisms of disease pathogenesis, putative targets for the actions of antibodies, and targets for novel therapeutic agents. She also leads clinical projects with an emphasis on detailed clinical phenotyping which permits early recognition and diagnosis of these conditions, evaluating therapeutic responses, identifying the most effective treatment algorithms, and determinating features that optimise patients' outcomes.
Dr Ramanathan completed her PhD on the clinical and immunological characterisation of myelin oligodendrocyte glycoprotein (MOG) antibody-associated demyelination. In 2016, she established and has since been the lead investigator of the Australasian and New Zealand MOG Study Group. This is a unique collaborative platform of over 150 adult and paediatric neurologists from over 45 centres throughout Australasia, with the goal of better understanding and treating antibody-associated demyelination. She heads this collaboration, and works closely with Professor Russell Dale (paediatric neurologist/ neuroimmunologist) and Associate Professor Fabienne Brilot (scientist) at the Kids Neuroscience Centre on these patients. This research team is now responsible for one of the largest international cohorts of close to 500 paediatric and adult patients with MOG antibody-associated demyelination, and have led a number of important publications for the field.
Dr Ramanathan has been the chief investigator for scholarships and grants providing research funding from the National Health and Medical Research Council (NHMRC) and the Brain Foundation.
研究兴趣
论文共 95 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Multiple sclerosis and related disorders (2024): 105408-105408
Mark J Kelly,Eleanor Grant, Andrew G Murchison,Sophie Binks,Sudarshini Ramanathan,Sophia Michael,Adam E Handel,Lahiru Handunnetthi,Christopher E Uy, John N Soltys,Divyanshu Dubey, Gregory S Day,
JAMA neurology (2024)
Ganesha Liyanage,Benjamin P. Trewin,Joseph A. Lopez, Jane Andersen,Fiona Tea,Vera Merheb, Kristy Nguyen,Fiona X. Z. Lee,Marzena J. Fabis-Pedrini,Alicia Zou,Ali Buckland,Anthony Fok,
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2024)
Annals of clinical and translational neurologyno. 4 (2024): 1053-1058
Avani Yeola,Aleha Pillay,Samuel Houston,Vicki Maltby, Marzena Pedrini, Linh Le-Kavanagh,Vera Merheb, Kristy Nguyen, Fiona Lee,Susan Walters, Marinda Taha, AnnMaree O'Connell,
引用0浏览0引用
0
0
Philipp Klyscz, Julian Haas,Hanna G. Zimmermann,Adi Wilf-Yarkoni,Alon Tiosano,Omer Bialer, Mark Hellman,Itay Lotan,Yamit Cohen-Tayar,Netta Levin, Adi Vaknin Dembinsky,Sara Mariotto,
MULTIPLE SCLEROSIS JOURNAL (2023): 141-142
引用0浏览0引用
0
0
ANNALS OF NEUROLOGY (2023): S55-S56
引用0浏览0引用
0
0
Neuroimmunology and Neuroinflammationno. 4 (2023): e200124-e200124
引用3浏览0引用
3
0
Journal of Affective Disorders Reports (2023): 100548-100548
MULTIPLE SCLEROSIS JOURNAL (2023): 635-636
引用0浏览0引用
0
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn